Atenolol Market - Top Companies and Manufacturers

Companies Dominating the Atenolol Landscape

Intas Pharmaceuticals Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Abbott Laboratories
F. Hoffmann-La Roche Ltd
Danaher Corporation
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Zydus Pharmaceuticals (USA) Inc.
Ipca Laboratories Limited
Unichem Laboratories Limited
AstraZeneca PLC

Browse Key Market Insights with Data Illustration:

Atenolol Market Size & Share, Growth Forecasts 2024-2036

In the News

Unichem Laboratories Limited obtained ANDA authorization from the United States Food and Drug Administration (USFDA) for its Atenolol and Chlorthalidone Tablets, USP 50 mg/25 mg and 100 mg/25 mg to be sold as a generic version of Alvogen Malta Operations Ltd's TENORETIC (atenolol and chlorthalidone) Tablets.
AstraZeneca PLC has approved the sale of the worldwide commercial rights Inderal (propranolol), Tenormin (atenolol), Tenoretic (atenolol, chlorthalidone fixed-dose combination), Zestril (lisinopril), and Zestoretic (lisinopril, hydrochlorothiazide fixed-dose combination) to Atnahs Pharma. This deal has eliminated the already sold rights in the United States and India, as well as the rights in Japan, which will be kept by AstraZeneca.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of atenolol is assessed at USD 12.15 Billion.

The atenolol market size was valued at USD 11.59 Billion in 2023 and is expected to reach USD 22.97 Billion by the end of 2036, expanding at around 5.4% CAGR during the forecast period i.e., between 2024-2036. Growing prevalence of angina experiences, expansion in sedentary lifestyle, and increasing prevalence of arrhythmia are the major factors driving the market growth.

North America is likely to be the largest with a share of about 40% by 2036, attributed to increasing prevalence of cardiac diseases, along with rising frequency of hypertension in the region.

Intas Pharmaceuticals Limited, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Zydus Pharmaceuticals (USA) Inc., Ipca Laboratories Limited, Unichem Laboratories Limited, AstraZeneca PLC

Atenolol Market - Top Companies and Manufacturers

Companies Dominating the Atenolol Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the atenolol market worth?

Why is the demand for atenolol growing?

Which region dominated the majority of atenolol industry share?

Who are the top atenolol companies?